Non-invasive drug delivery across the blood–brain barrier (BBB) represents a significant
advancement in treating neurological diseases. The BBB is a tightly packed layer of …

The emergence of nanomedicine drugs as a result of the fast advancement of
nanotechnology offers enormous potential for improving cancer treatment strategies. The …

The increase in cancer cases is undoubtedly affecting the development of new therapeutic
approaches. Polymeric nanoparticles are of great interest. Due to their relatively small size …

Artificial, de-novo manufactured materials (with controlled nano-sized characteristics) have
been progressively used by neuroscientists during the last several decades. The …

Wearable sensors and invasive devices have been studied extensively in recent years as
the demand for real-time human healthcare applications and seamless human–machine …

Hydrogels have immense potential in revolutionizing central nervous system (CNS) drug
delivery, improving outcomes for neurological disorders. They serve as promising tools for …

Brain cancers, especially glioblastoma multiforme, are associated with poor prognosis due
to the limited efficacy of current therapies. Nanomedicine has emerged as a versatile …

Primary brain cancer or brain cancer is the overgrowth of abnormal or malignant cells in the
brain or its nearby tissues that form unwanted masses called brain tumors. People with …

Glioblastoma (GBM) represents almost half of primary brain tumors, and its standard
treatment with the alkylating agent temozolomide (TMZ) is not curative. Treatment failure is …

Glioblastoma, also referred to as glioblastoma multiforme (GBM), is grade IV astrocytoma
characterized by being fast-growing and the most aggressive brain tumor. In adults, it is the …